Piperazinyl CCR1 antagonists - optimization of human liver microsome stability

被引：14

作者：

Brown, Matthew F. ^{[1
]}

Bahnck, Kevin B. ^{[1
]}

Blumberg, Laura C. ^{[1
]}

Brissette, William H. ^{[1
]}

Burrell, Sara A. ^{[1
]}

Driscoll, James P. ^{[1
]}

Fedeles, Flavia ^{[1
]}

Fisher, Michael B. ^{[1
]}

Foti, Robert S. ^{[1
]}

Gladue, Ronald P. ^{[1
]}

Guzman-Martinez, Aikomari ^{[1
]}

Hayward, Matthew M. ^{[1
]}

Lira, Paul D. ^{[1
]}

Lillie, Brett M. ^{[1
]}

Lu, Y. ^{[1
]}

Lundquist, Greg D. ^{[1
]}

McElroy, Eric B. ^{[1
]}

McGlynn, Molly A. ^{[1
]}

Paradis, Timothy J. ^{[1
]}

Poss, Christopher S. ^{[1
]}

Roache, James H. ^{[1
]}

Shavnya, Andrei ^{[1
]}

Shepard, Richard M. ^{[1
]}

Trevena, Kristen A. ^{[1
]}

Tylaska, Laurie A. ^{[1
]}

机构：

[1] Pfizer Global Res & Dev, Groton, CT 06340 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 11期

关键词：

BX471; CP-481715; CCR1; antagonist;

D O I：

10.1016/j.bmcl.2007.03.037

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：3109 / 3112

页数：4

共 15 条

[1] Novel CCR1 antagonists with improved metabolic stability [J].

Brown, MF ;

Avery, M ;

Brissette, WH ;

Chang, JH ;

Colizza, K ;

Conklyn, M ;

DiRico, AP ;

Gladue, RP ;

Kath, JC ;

Krueger, SS ;

Lira, PD ;

Lillie, BM ;

Lundquist, GD ;

Mairs, EN ;

McElroy, EB ;

McGlynn, MA ;

Paradis, TJ ;

Poss, CS ;

Rossulek, MI ;

Shepard, RM ;

Sims, J ;

Strelevitz, TJ ;

Truesdell, S ;

Tylaska, LA ;

Yoon, K ;

Zheng, DY .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) :2175-2179

[2]

CLOG D, ACD LABS CALCULATOR

[3] Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 [J].

Cole, KE ;

Strick, CA ;

Paradis, TJ ;

Ogborne, KT ;

Loetscher, M ;

Gladue, RP ;

Lin, W ;

Boyd, JG ;

Moser, B ;

Wood, DE ;

Sahagan, BG ;

Neote, K .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) :2009-2021

[4] Chemokine-dependent upregulation of CD11b on specific leukocyte subpopulations in human whole blood: Effect of anticoagulant on RANTES and MIP-1 beta stimulation [J].

Conklyn, MJ ;

Neote, K ;

Showell, HJ .

CYTOKINE, 1996, 8 (10) :762-766

[5]

Gladue Ronald P, 2004, Curr Opin Investig Drugs, V5, P499

[6] Chemokine blockade and chronic inflammatory disease: proof of concept in patients with rheumatoid arthritis [J].

Haringman, JJ ;

Kraan, MC ;

Smeets, TJM ;

Zwinderman, KH ;

Tak, PP .

ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (08) :715-721

[7]

HILGER CS, 2002, Patent No. 2002036581

[8] BX471: A CCR1 antagonist with anti-inflammatory activity in man [J].

Horuk, R .

MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (09) :791-804

[9] The discovery of structurally novel CCR1 antagonists derived from a hydroxyethylene peptide isostere template [J].

Kath, JC ;

DiRico, AP ;

Gladue, RP ;

Martin, WH ;

McElroy, EB ;

Stock, IA ;

Tylaska, LA ;

Zheng, DY .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) :2163-2167

[10] Potent small molecule CCR1 antagonists [J].

Kath, JC ;

Brissette, WH ;

Brown, MF ;

Conklyn, M ;

DiRico, AP ;

Dorff, P ;

Gladue, RP ;

Lillie, BM ;

Lira, PD ;

Mairs, EN ;

Martin, WH ;

McElroy, EB ;

McGlynn, MA ;

Paradis, TJ ;

Poss, CS ;

Stock, IA ;

Tylaska, LA ;

Zheng, DY .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) :2169-2173

← 1 2 →